Immune checkpoint inhibitor therapy in COPD-concomitant lung cancer: A review of efficacy outcomes and mechanistic insights

Cancer Letters · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles